Either there's equity dilution (new shares issued) or asset dilution (licensing/selling the rights, or a share of the rights). What's better all depends on the details, but there's not necessarily that much difference from a shareholder's perspective.
Ann: Opthea Announces Plans for Potential US listing and IPO, page-20
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
54.3¢ |
Change
0.003(0.46%) |
Mkt cap ! $670.9M | |||
| Open | High | Low | Value | Volume |
| 54.5¢ | 56.0¢ | 53.8¢ | $411.0K | 751.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 8361 | 54.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.5¢ | 66881 | 17 |
View Market Depth
| Last trade - 14.30pm 27/08/2024 (20 minute delay) ? |
| OPT (ASX) Chart |